Hemo Organic

Hemo Organic EBITDA per Share

The EBITDA per Share of Hemo Organic (524590.BO) as of Oct 20, 2026 is -0.13 INR. In the previous year, EBITDA per Share was -0.71 INR — a change of -82.08% (higher).

EBITDA per Share

-0.13INR

YoY

-82.08%

Last updated:

EBITDA per Share of Hemo Organic is 2025 -0.13 INR. EBITDA per Share of Hemo Organic was 2024 -0.71 INR. It decreases by -82.08% higher compared to the previous year.

The Hemo Organic EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2023
-0.16 INR
Jan 1, 2024
-0.71 INR
Jan 1, 2025
-0.13 INR
The Hemo Organic EBITDA per Share history
YEAREBITDA per ShareYoY
-0.13INR-82.08%
-0.71INR+343.01%
-0.16INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hemo Organic Stock analysis

What does Hemo Organic do? Hemo Organic Ltd develops chloro chemicals for pharmaceuticals and leather industry applications. The company manufactures ayurvedic and unani pharmaceutical preparations. It produces chemical products, pharmaceuticals, and medical chemicals. The firm's primary customers include pharmaceutical manufacturers and leather industry producers who purchase its chloro chemicals. The company's manufacturing focus on ayurvedic and unani pharmaceuticals targets traditional medicine segments. Hemo Organic Ltd serves the pharmaceutical and leather sectors with its chemical solutions. Hemo Organic Ltd specializes in chloro chemical development for pharmaceutical and leather industry use. The firm's ayurvedic and unani pharmaceutical manufacturing caters to traditional medicine markets. Chemical and medical chemical production supports both pharmaceutical and leather industry needs. The company's products are sold to manufacturers in the pharmaceutical sector and leather processing industry. Its business model centers on supplying chemical solutions to these two industrial segments. Hemo Organic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hemo Organic stock

EBITDA per Share of Hemo Organic is -0.13 INR in 2025.

EBITDA per Share of Hemo Organic changed from -0.71 INR to -0.13 INR, representing a -82.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Hemo Organic since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Hemo Organic

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Hemo Organic